Technologies / cdnjs
cdnjs
541 companies recorded in cdnjs, page 1 of 6.
| Company | Country | Stage | Raised |
|---|---|---|---|
| 1910 | US | series-a | $5.0M |
| AbInitio Bio | GB | seed | $1.0M |
| Abound | GB | series-b+ | $1.7B |
| Abound | GB | series-b+ | $400.1M |
| Above Security | US | series-a | $50.0M |
| Acai Travel | ES | seed | $4.0M |
| Actithera | NO | series-a | $86.4M |
| ACX | US | seed | $1.0M |
| AEROCINE VENTURES, INC. | US | unknown | $1.9M |
| AFFERENCE INC | US | unknown | $15.3M |
| Agaton | SE | seed | $10.8M |
| AIMon | US | seed | $2.0M |
| AiPrise | US | series-a | $17.0M |
| Airmettle Inc | US | unknown | $1.1M |
| Airmo | DE | seed | $5.8M |
| Akur8 | FR | series-b+ | $180.0M |
| Albert | US | series-b+ | $1.0M |
| Alexi | US | series-a | $11.0M |
| Allica Bank | GB | series-b+ | $500.0M |
| Alphaguard | FR | seed | $1.0M |
| Altris | SE | unknown | $25.0M |
| Angle Health | US | series-b+ | $196.0M |
| AppFactor | GB | seed | $4.3M |
| Approov | GB | series-a | $16.2M |
| April | US | series-b+ | $78.0M |
| Arcnano, Inc. | US | unknown | $2.0M |
| Argil | FR | seed | $6.3M |
| Arketa | US | series-a | $5.0M |
| Armadin | US | series-a | $189.9M |
| Artie | US | seed | $1.0M |
| Assaia | CH | series-b+ | $46.4M |
| Assemblio | DE | unknown | $2.3M |
| AssetCool | GB | series-a | $12.4M |
| Assort Health | US | series-b+ | $72.0M |
| Astra Security | US | seed | $2.7M |
| Astromech AI Corp. | US | unknown | $10.5M |
| Athos Therapeutics, Inc. | US | unknown | $10.3M |
| AtoB | US | series-a | $5.0M |
| ATSP Innovations, Inc. | US | unknown | $3.2M |
| attimet | US | seed | $1.0M |
| Auctor | US | seed | $1.0M |
| AURIGA SPACE, INC | US | unknown | $1.2M |
| Automat | US | series-a | $15.5M |
| Auxilia, Inc. | US | unknown | $1.4M |
| Avenue Biosciences | FI | seed | $2.5M |
| Avenzo Therapeutics | US | series-a | $150.0M |
| Axle Health | US | series-a | $5.0M |
| AXOFT, INC. | US | unknown | $34.2M |
| BANC 3, INC. | US | unknown | $2.0M |
| Beglaubigt.de | US | seed | $1.0M |
| Ben | GB | series-b+ | $27.0M |
| Betaglue Technologies | IT | unknown | $33.6M |
| Beycome | US | seed | $2.5M |
| BIG METAL ADDITIVE LLC | US | unknown | $2.0M |
| Bio Usawa Inc. | US | unknown | $1.7M |
| Bio-Sourcing | BE | unknown | $2.7M |
| Biomesense INC | US | series-b+ | $1.2M |
| Blee | US | series-a | $5.0M |
| Bloq.it | PT | series-b+ | $30.2M |
| BlossomHill Therapeutics | US | series-b+ | $84.0M |
| Blue Water Autonomy | US | series-a | $64.0M |
| Blue Water Autonomy | US | series-a | $64.0M |
| BlueFlag Security Inc. | US | unknown | $10.0M |
| Boldr | GB | seed | $3.2M |
| Bolto | US | seed | $12.0M |
| Bono | US | pre-seed | $1.6M |
| Bonum Therapeutics, Inc. | US | unknown | $26.9M |
| Booster (Fresh People) | ES | seed | $376,300 |
| BotCity | US | series-a | $5.0M |
| Bounce Insights | IE | series-a | $4.5M |
| BRAINCHIP, INC | US | unknown | $1.8M |
| Brenus Pharma | FR | series-a | $24.0M |
| Bridgetown Research | US | seed | $1.0M |
| BriefCatch | US | series-a | $7.5M |
| Brite | US | series-a | $5.0M |
| BVNK | GB | series-b+ | $95.0M |
| C the Signs | GB | series-a | $10.0M |
| Caliza Financial Technologies, Inc. | US | unknown | $2.3M |
| Callyope | FR | unknown | $2.7M |
| Cambio | US | series-a | $5.0M |
| CAMBRIAN WORKS, INC. | US | unknown | $1.8M |
| Campfire Software, Inc. | US | unknown | $39.1M |
| Candid Health | US | series-b+ | $100.0M |
| CANOPY AEROSPACE, INC. | US | unknown | $2.0M |
| CAPELLA SPACE CORP | US | unknown | $10.0M |
| CARBON TO STONE, INC. | US | unknown | $1.6M |
| Carmoola | GB | series-b+ | $139.7M |
| CasaPerks | US | seed | $15.8M |
| Casca | US | pre-seed | $3.9M |
| Catalyx Space | US | seed | $7.1M |
| CELLIBRE, INC. | US | unknown | $2.0M |
| Centaur | US | series-a | $5.0M |
| Cents | US | series-b+ | $77.0M |
| CeQur | CH | series-b+ | $120.0M |
| Cercli | unknown | seed | $5.0M |
| Cernel | DK | seed | $5.1M |
| CesiumAstro Inc. | US | unknown | $270.5M |
| CFD Research Corporation | US | unknown | $2.0M |
| CHAOS 1, INC. | US | unknown | $1.7M |
| Chapsvision | FR | series-b+ | $200.0M |